According to the current analysis of Reports and Data, the global Organic Medicinal Herbs market was valued at USD 346.03 Million in 2020 and is expected to reach USD 533.21 Million by year 2027, at a CAGR of 6.37%. With the rising public awareness and the global demand of efficacious herbal products, the organic cultivation of medicinal plants is the need of the hour. In organic farming, crop cultivation depends on the use of organic (natural) ingredients and avoids the use of synthetic chemical inputs (herbicides, fertilizers, pesticides), and genetically modified organism seeds.

Consumers in developed countries are becoming more attentive to natural products; and are demanding more information on the ingredients and the additives found in their food, drink and health products – including information on processes used to grow the plant raw materials used in the products they are purchasing. In some situations they are also willing to pay higher prices. The demand for local, organic herbs is rapidly growing with the recovery of herbalism and cohesive medicine.

 Organic Medicinal Herbs Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  

Further key findings from the report suggest:

• Echinacea herb is being studied for use in combating protozoan, viral, bacterial and fungal infections. The herb is also used as an anti-inflammatory agent, and as a possible chemo preventative agent. Active constituents in the herb vary according to the three main species and include essential oils, flavonoids, polyacetylenes, alkylamides, caffeic acid derivatives (primarily echinocoside), and polysaccharides. It is expected to grow at a CAGR of 5.83%
• Many of herbs are majorly native to the Americas, such as Echinacea, and stinging nettles, and lavender. Their ability to support pollinators and their inclination to grow in diverse communities make them valuable for existing operations.
• The utilization of medicinal plants are: direct utilization in the form of plant parts (root, stem, leaf, seed, and bark), powder, extracts, medicinal chemicals (alkaloids, glycosides) and plant drugs
• According to an estimate by the World Health Organization, around 4 billion people in the world use herbal medicines for their primary healthcare needs
• Neither herbal medicines nor organic medicines are regulated in many countries, including developed countries like United States. Many of these medicines are sold as dietary supplements and can be consumed without a prescription
• Echinacea is one of the popular types of medicinal plants. These plant’s blooms have been used for centuries as medicine in juice, tea and extracts. Currently, they can be taken as supplements and powders. The best-known use of Echinacea is to reduce symptoms of the common cold. The plant is widely used to strengthen the immune system and fight infections Treats and also help avert urinary tract infections
• On the basis of product, the extract segment is estimated to be the largest segment in the market at USD 258.90 Million in 2020. Organic medicinal herb extracts are plant extracts, which have medicinal properties and are a rich source of several active compounds, such as alkaloids, steroids, tannins, glycosides, volatile oils, phenols, and flavonoids
• A lot of developments are taking place in the end-use industries to serve consumer needs, thereby aiding in the evolution of these industries. One single extract can be used for multiple applications when used in combination with other extracts or ingredients; for instance, ashwagandha extract is used for hiccups, arthritis, asthma, insomnia, tuberculosis, leukoderma, bronchitis and chronic liver diseases. As a result of this diversity, there is a broad scope of growth for end-user industries
• The major driving factors for powdered organic medicinal herb extracts are cost-effectiveness, greater dosing flexibility, superior absorption, stability and bioavailability, low dusting nature. The ease in handling the product while mixing it as a food additive, feed additive, pharmaceutical, or nutraceutical ingredient is also expected to propel the market growth at a CAGR of 6.18%
• Asia Pacific is projected to be the fastest-growing segment in the global market due to the extensive use of herbal medicine in many parts of the region

 Top Companies Profiled in the Report Include:

Young Living, Symrise AG, Firmenich, Worlee Group, Kangcare Bioindustry Co, Ltd, Sunrise Nutrachem, Organic Spices, Inc., Frontier Natural Products Co-op, Native Extracts Pty Ltd and New Zealand Botanicals among others

Additionally, the report consists a detailed analysis of the segmentation of the PTA Balloon Cathetery tests Market based on product types and end-use/application offered in the PTA Balloon Cathetery tests Market –

Herb (Revenue, USD Million; 2017–2027)

• Echinacea
• Rosemary
• Sage
• Myrtle
• Thyme
• NML
• Chives
• Mint
• Multi-herb Products
• Others

Source (Revenue, USD Million; 2017–2027)

• Leaves
• Roots
• Fruits
• Others

Product (Revenue, USD Million; 2017–2027)

• Extracts
• Essential Oil

Form (Revenue, USD Million; 2017–2027)

• Powder
• Liquid

End Use (Revenue, USD Million; 2017–2027)

• Medicinal
• Functional food beverage
• Others

Key Regional Markets Studied in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request for Customization this report - https://www.reportsanddata.com/request-customization-form/3313

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.